Spruchbuch für jüdische Schulen

bearb. von A. Horwitz und M. Steinschneider

[Bd 1]

[Mehr nicht erschienen]. Enthält handschriftliche Bemerkungen von A. Berliner

Rabbiner Abraham Kohn, ein Märtyrer seiner Zeit : eine biographische Skizze

von Veit Friedrich Manheimer

Beitraege zur Sprach- und Alterthumsforschung : aus jüdischen Quellen

von Michael Sachs

Auswahl historischer Stücke aus hebräischen Schriftstellern vom zweiten Jahrhundert bis auf die Gegenwart : für Theologen und Historiker, so wie zum Gebrauch in höheren jüdischen Lehranstalten ; mit vokalisirtem Texte, deutscher Übers. u. Anm.

[Verf.: Josef Zedner]

Stimmen vom Jordan und Euphrat : ein Buch für's Haus

von Michael Sachs. Mit Beitr. von Moritz Veit

Die religiöse Poesie der Juden in Spanien

von Michael Sachs

Intravitreal ranibizumab monotherapy to treat retinopathy of prematurity zone II, stage 3 with plus disease.

BACKGROUND Treatment of retinopathy of prematurity (ROP) stage 3 plus with bevacizumab is still very controversial. We report the outcome of 6 eyes of 4 premature infants with ROP stage 3 plus disease treated with ranibizumab monotherapy. METHODS Six eyes of 4 premature infants with threshold ROP 3 plus disease in zone II, were treated with one intravitreal injection of 0.03 ml ranibizumab. No prior laser or other intravitreal therapy was done. Fundus examination was performed prior to the intervention and at each follow-up visit. Changes in various mean vital parameters one week post intervention compared to one week pre-intervention were assessed. RESULTS The gestational age (GA) of patient 1, 2, 3, and 4 at birth was 24 5/7, 24 5/7, 24 4/7, and 26 1/7 weeks, respectively. The birth weight was 500 grams, 450 grams, 665 grams, and 745 grams, respectively. The GA at the date of treatment ranged from 34 3/7 to 38 6/7 weeks. In one infant, upper air way infection was observed 2 days post injection of the second eye. Three eyes required paracentesis to reduce the intraocular pressure after injection and to restore central artery perfusion. After six months, all eyes showed complete retinal vascularisation without any signs of disease recurrence. CONCLUSIONS Treatment of ROP 3 plus disease with intravitreal ranibizumab was effective in all cases and should be considered for treatment. One infant developed an upper air way infection suspicious for nasopharyngitis, which might be a possible side effect of ranibizumab. Another frequent complication was intraocular pressure rise after injection. More patients with longer follow-up duration are mandatory to confirm the safety and efficacy of this treatment. TRIAL REGISTRATION NUMBER NCT02164604 ; Date of registration: 13.06.2014.

Landscape Transformation and Sustainable Development in Ethiopia: Background information for a study tour through Ethiopia, 4-20 September 2006

This report presents background material used by participants in a joint Ethiopian-Swiss study tour through the north-central highlands of Ethiopia. The main theme of the tour was 'land transformation and sustainable development'. The tour took place from 4-20 September 2006, starting in Addis Abeba and continuing through North Shewa, Wello, Gonder and Gojam. This report is a structured compilation of information gathered by MSc candidates and scientists from the University of Bern prior to the study tour, and supplemented with daily reports by all participants after the study tour was completed.

Wir sind das Salz der Erde : Wacht! daß sie nicht versalzen werde!

Bibliograph. Nachweis: Wolf, Sylvia: Politische Karikaturen in Deutschland 1848/49. Mittenwald 1982. – vgl. 1.27 Nr. 68

Volksversammlung in Heidelberg : Das ist mein Liebersohn an dem ich wohlgefallen habe

Bibliograph. Nachweis: Wolf, Sylvia: Politische Karikaturen in Deutschland 1848/49. Mittenwald 1982. – 1.55 Nr. 2